Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology

Brain. 2017 Jul 1;140(7):e39. doi: 10.1093/brain/awx108.

Authors

Cira Dansokho^{1

2}, Pierre Aucouturier^{1

2}, Guillaume Dorothée^{1

2}

Affiliations

¹ INSERM, UMRS 938, CdR Saint-Antoine, Laboratory Immune System, Neuroinflammation and Neurodegenerative Diseases, Hôpital Saint-Antoine, F-75012, Paris, France.
² Sorbonne Universités, UPMC Univ Paris 06, UMRS 938, CdR Saint-Antoine, Hôpital Saint-Antoine, F-75012, Paris, France.

PMID: 28498909
DOI: 10.1093/brain/awx108

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Alzheimer Disease*
Amyloidosis*
Animals
Immunomodulation
Interleukin-2
Memory
Mice

Substances

Interleukin-2